Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

An in vitro screening system for the nephrotoxicity of various platinum coordination complexes

A cytochemical study

Summary

Isolated rat kidney tubules were cultured in Earle's medium with and without the platinum coordination complexes. Aliquots were taken at 0, 1, 2, 3, 4, 5, 6, and 8 h and analyzed for the amount of Na+/K+-ATPase, Ca2+-ATPase, alkaline phosphatase, and acid phosphatase. Culture medium was also analyzed biochemically for the amounts of alkaline phosphatase present. There is a decrease in the various enzymes levels of the tubules after incubation in nephrotoxic analogues with a corresponding increase in the culture medium. These results compare favorably with in vivo studies. The alkaline phosphatase monitored in the rat kidney cross sections from both the normal and the drug-treated animals at 0, 3, 5, 10, and 20 days showed a correlation in the decrease of enzyme levels in the kidney with a corresponding increase in the urinary levels in both the Wistar and the Long Evans rats. The baseline levels were higher in the Long Evans rats than in the Wistar rats. After cisplatin (nephrotoxic) treatment the Long Evans rats had twice as much alkaline phosphatase in the urine at day 5 as the Wistar rats. Rats treated with cyclobutanedicarboxylatoplatinum (II) did have some alkaline phosphatase output in the urine in excess of the normal levels, but this increase was not so highly significant as to justify classifying the drug as nephrotoxic.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Aggarwal SK (1974) Inhibition of cytokinesis in mammalian cells by cis-dichlorodiammineplatinum (II). Cytobiologie 8: 395

  2. 2.

    Aggarwal SK (1979) Effects of cis-dichlorodiammineplatinum (II) on the microfilaments and inhibition of cytokinesis. J Cell Biol 83: 327a

  3. 3.

    Aggarwal SK, Broomhead JA, Fairlie DP, Whitehouse MW (1980a) Platinum drugs: Combined anti-proliferative and nephrotoxicity assay in rats. Cancer Chemother Pharmacol 4: 249

  4. 4.

    Aggarwal SK, Whitehouse MW, Ramachandran C (1980b) Ultrastructural effects of cisplatin. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: current status and new developments. Academic, New York, pp 79–111

  5. 5.

    Barrnett RJ, Seligman AM (1952) Histochemical demonstration of proteinbound sulfhydryl groups. Science 116: 323

  6. 6.

    Batzer MA, Thieme PO Jr, Weber ML, Aggarwal SK (1984) Nephrotoxicity assays for anti-tumor platinum coordination complexes using membrane associated enzymes: An in vivo and in vitro screen system. J Cell Biol 99: 291 a

  7. 7.

    Borgers M (1973) The cytochemical application of new potent inhibitors of alkaline phosphatases. J Histochem Cytochem 21: 812

  8. 8.

    Cutler L, Rodan G, Feinstein MB (1978) Cytochemical localization of adenylate cyclase and of calcium ion, magnesium, ion-activated ATPases in the dense tubular system of human blood platelets. Biochim Biophys Acta 542: 357

  9. 9.

    DeRenzis FA, Schectman A (1973) Staining by neutral red and trypan blue in sequence for assaying vital and nonvital cultured cells. Stain Technol 48: 135

  10. 10.

    Engel MB, Zerlotti E (1963) The histochemical visualization of protein bound sulfhydryl groups with an azomercurial reagent. J Histochem Cytochem 12: 156

  11. 11.

    Fewtrell CMS, Gomperts BD (1977) Quercetin: A novel inhibitor of Ca2+ influx and exocytosis in rat peritoneal mast cells. Biochim Biophys Acta 469: 52

  12. 12.

    Goldin SM (1979) Identification of the Na+/K+-ATPase-driven active transport system by reconstitution: Its role in active ion resorbtion in the kidney. In: Skou JC, Norby JG (eds) Na+ K+-ATPase structure and kinetics. Academic, New York, pp 69–85

  13. 13.

    Goldstein RS, Mayor GH (1983) Minireview: The nephrotoxicity of cisplatin. Life Sci 32: 685

  14. 14.

    Goldstein RS, Noordewier B, Bond JT, Hook JB, Mayor GH (1981) cis-Dichlorodiammineplatinum nephrotoxicity: Time course and dose response of renal functional impairment. Toxicol Appl Pharmacol 60: 163

  15. 15.

    Gottlieb JA, Drewinko B (1975) Review of the current clinical status of platinum coordination complexes in cancer chemotherapy. Cancer Chemother Rep 59: 621

  16. 16.

    Hugon J, Borgers M (1966). A direct lead method for electron microscopic visualization of alkaline phosphatase activity. J Histochem Cytochem 14: 429

  17. 17.

    Hydes PC (1984) Synthesis and testing of platinum analoguesan an overview. In: Hacker MP, Douple EB, Krakoff IH (eds) Platinum coordination complexes in cancer chemotherapy. Nijhoff, Boston, pp 216–227

  18. 18.

    Kramer MTC, Catovsky D, Foa R (1978) Cell membrane enzymes: alkaline phosphatase and alkaline phosphodiesterase I in normal and leukaemic lymphocytes. Br J Haematol 40: 111

  19. 19.

    Leathwood PD, Plummer DT (1969) Enzymes in rat urine. Enzymologia 37: 240

  20. 20.

    Marchesi VT, Palade GE (1967) The localization of Mg-Na-K-activated adenosine triphosphatase on red cell ghost membranes. J Cell Biol 35: 387

  21. 21.

    Nagata N, Rasmussen, H (1970) Renal gluconeogenesis: Effects of Ca2+ and H+. Biochim Biophys Acta 215: 1

  22. 22.

    Oliver C (1980) Cytochemical localization of acid phosphatase and tri-meta phosphatase activities in exocrine acinar cells. J Histochem Cytochem 27: 78

  23. 23.

    Rose WC, Brabner WT (1984) Experimental antitumor activity of platinum coordination complexes. In: Hacker MP, Douple EB, Krakoff IH (eds) Platinum coordination complexes in cancer chemotherapy. Nijhoff, Boston, pp 228–239

  24. 24.

    Schurig JE, Bradner WT, Huftalen JB, Doyle GJ, Gylys JA (1980) Toxic side effects of platinum analogs. In: Prestayko AW, Crooke ST, Carter SK (eds) Cisplatin: current status and new developments. Academic, New York, pp 227–236

  25. 25.

    Siddik ZH, Newell DR, Boxall FE, Jones M, McGhee KG, Harrap KR (1984) Bilary excretion, renal handling and red cell uptake of cisplatin and CBDCA in animals. In: Hacker MP, Douple EB, Krakoff IH (eds) Platinum coordination complexes in cancer chemotherapy. Nijhoff, Boston, pp 90–102

  26. 26.

    Stekhoven FS, Bonting SL (1981) Transport adenosine triphosphatases: Properties and functions. Physiol Rev 61: 1

  27. 27.

    Uusitalo RJ, Karnovsky MJ (1977) Surface localizaiton of 5′-nucleotidase on the mouse lymphocyte. J Histochem Cytochem 25: 87

  28. 28.

    Vermorken JB, ten Bokkel Huinink WW, McVie JG, van der Vijgh WJF, Pinedo HM (1984) Clinical experience with 1,1-diaminomethylcyclohexan (sulphato) platinum (II) (TNO-6). In: Hacker MP, Douple EB, Krakoff IH (eds) Platinum coordination complexes in cancer chemotherapy. Nijhoff, Boston, pp 330–343

  29. 29.

    Wachsmuth TD (1981) Quantification of nephrotoxicity in rabbits by automated morphometry of alkaline phosphatasestained kidney sections. Histochemistry 71: 235

Download references

Author information

Correspondence to Surinder K. Aggarwal.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Batzer, M.A., Aggarwal, S.K. An in vitro screening system for the nephrotoxicity of various platinum coordination complexes. Cancer Chemother. Pharmacol. 17, 209–217 (1986). https://doi.org/10.1007/BF00256686

Download citation

Keywords

  • Platinum
  • Alkaline Phosphatase
  • Normal Level
  • Baseline Level
  • Acid Phosphatase